N-Nitroso Dasatinib NEW

N-Nitroso Dasatinib; C22H25ClN8O3S 

• 
  

• Product Information

• Product Number: D015061

• English Name: N-Nitroso Dasatinib

• English Alias: N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)(nitroso)amino)thiazole-5-carboxamide

• CAS Number: None

• Molecular Formula: C₂₂H₂₅ClN₈O₃S

• Molecular Weight: 517.00

• Advantages

• As a nitroso derivative impurity of Dasatinib, this compound has the following advantages:
• 
  

• Well-defined with distinct functional groups: Contains thiazole-5-carboxamide core, 2-(nitrosoamino) substituent, 6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidine side chain, and N-(2-chloro-6-methylphenyl)amide. Unlike dasatinib (tyrosine kinase inhibitor with amino group at this site), its nitrosoamide (-N-NO) polarity, chlorine electronegativity, and polycyclic hydrophobicity create significant differences, enabling precise differentiation via HPLC/ion-pair chromatography as a specific marker;

• High stability and traceability: Rigid thiazole/pyrimidine/benzene structures and stability of amide/nitrosoamide ensure stability under dark, low-temperature conditions. As a derivative from amine nitrosation during storage/synthesis, it directly reflects amino stability and nitrite exposure, improving impurity tracing accuracy;

• High detection sensitivity: Polycyclic conjugation shows strong UV absorption (240-280nm), combined with m/z 518 [M+H]⁺ enabling ppb-level analysis via LC-MS, compatible with tyrosine kinase inhibitor nitroso impurity systems.

• Applications

• Pharmaceutical quality control: Used as an impurity reference standard to quantify N-Nitroso Dasatinib in APIs, ensuring compliance with genotoxic impurity limits in pharmaceutical standards;

• Stability studies: Monitoring impurity levels under varying conditions (pH, light) to assess degradation trends and support shelf-life assurance;

• Synthesis assessment: Evaluating purity of amino-containing intermediates in dasatinib synthesis to reduce nitrosation risk at the source.

• Background Description

• Dasatinib contains a pyrimidine-linked amino group, which may undergo nitrosation upon exposure to nitrous acid (e.g., from nitrate reduction), forming nitrosoamino derivatives like N-Nitroso Dasatinib. Due to potential genotoxicity, nitroso impurities are strictly regulated, and their residues may affect dasatinib safety, making detection and control critical for quality assurance.

• Research Status

• Current research focuses on:
• 
  

• Analytical method validation: Developing UPLC-MS/MS methods with C18 columns for separation, achieving 0.01 ppb detection limits;

• Nitrosation mechanism: Studying impurity formation kinetics under varying nitrite concentration and pH to clarify pyrimidine amino-to-nitrosoamide conversion pathways;

• Control strategies: Exploring nitrosation inhibitors (e.g., ascorbic acid) to keep impurity levels below safety limits (<0.001%);

• Toxicity evaluation: Conducting in vitro genotoxicity tests (e.g., Ames test, micronucleus assay) to assess potential hazards and support limit setting.

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com